These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8851103)

  • 1. AgNOR evaluation by image processing methods. Staining modifications and results in 126 invasive ductal breast carcinomas.
    Giménez-Mas JA; Gallego-Calvo P; Sanz-Moncasi P; Ríos-Mitchell J; Valero I; Sanz-Anquela M; Burriel J; Bavai A
    Anal Quant Cytol Histol; 1996 Feb; 18(1):9-18. PubMed ID: 8851103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
    Guski H; Hufnagl P; Kaufmann O; Krause M; Winzer KJ
    Anal Quant Cytol Histol; 2000 Jun; 22(3):206-12. PubMed ID: 10872036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma.
    Aubele M; Auer G; Jütting U; Falkmer U; Gais P
    Anal Quant Cytol Histol; 1994 Jun; 16(3):211-8. PubMed ID: 7522453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of AgNORs in breast cancer].
    Aubele M; Auer G; Jütting U
    Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different proliferation patterns in breast cancer: AgNOR measurements in ER-negative and ER-positive tumor cells.
    Günther L; Hufnagl P; Winzer KJ; Guski H
    Anal Cell Pathol; 2000; 20(4):155-62. PubMed ID: 11205318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolus organizer regions (AgNORs) in ductal mammary carcinoma. Comparison with classifications and prognosis.
    Aubele M; Auer G; Gais P; Jütting U; Rodenacker K; Voss A
    Pathol Res Pract; 1994 Feb; 190(2):129-37. PubMed ID: 7520163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
    Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
    Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
    Biesterfeld S; Ruoss E; Hufnagl P; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
    Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
    Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AgNOR and breast cancer. A study by image analysis.
    Ronco A; Larran J; López A; Vilches J
    Histol Histopathol; 1994 Apr; 9(2):309-13. PubMed ID: 8075491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions relate to growth fractions in human breast carcinoma.
    Raymond WA; Leong AS
    Hum Pathol; 1989 Aug; 20(8):741-6. PubMed ID: 2473025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
    Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer regions in human breast cancer.
    Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
    Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argyrophilic nucleolar organizer region (AgNOR) area per nucleus as a prognostic factor in breast cancer.
    Nakayama K; Abe R
    J Surg Oncol; 1995 Nov; 60(3):160-7. PubMed ID: 7475065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast.
    Canepa M; Gambini C; Borgiani L; Pastorino A; Buccaran G; Gallo L; Storace A; Rovida S
    Pathologica; 1993; 85(1096):151-62. PubMed ID: 8395684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor proliferative fraction in infiltrating duct carcinoma.
    Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
    Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity is a significant prognostic factor in male breast carcinoma.
    Pich A; Margaria E; Chiusa L
    Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative AgNOR assessment of cancer cell populations in undifferentiated nasopharyngeal carcinoma.
    Chen M; Lee JC; Lo S
    Anal Quant Cytol Histol; 2002 Apr; 24(2):89-92. PubMed ID: 12026056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.